| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
4
3
5
2
5
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
The fund invests in stocks of companies, both foreign and domestic, that pass its various screens.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.93 | 2.93 |
| Stocks | 78.1 | 78.1 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.38 | 0.38 |
| Foreign Stocks | 18.58 | 18.58 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Eli Lilly and Company | LLY | 10.97 | 2.88 |
| Nike, Inc. Class B | NKE | 23.2 | 2.65 |
| Colgate-Palmolive Company | CL | 15.21 | 2.57 |
| Pfizer Inc | PFE | 16.19 | 2.51 |
| W.W. Grainger, Inc. | GWW | 19.43 | 2.45 |
| Canadian National Railway Co | CNI | 6.54 | 2.41 |
| Bristol-Myers Squibb Company | BMY | 24.03 | 2.39 |
| Novartis AG ADR | NVS | 18.86 | 2.32 |
| Honeywell International, Inc. | HON | 14.92 | 2.29 |
| PepsiCo Inc | PEP | 20.92 | 2.29 |
